Características clínico-patológicas de la podocitopatía por glomeruloesclerosis focal y segmentariapor microscopia electrónica en la región caribe colombiana

datacite.rightshttp://purl.org/coar/access_right/c_16ecspa
dc.contributor.advisorAroca Martínez, Gustavo José
dc.contributor.advisorGuido Musso, Carlos
dc.contributor.advisorGonzález Torres, Henry J.
dc.contributor.authorSepúlveda Ospino, Carlos José
dc.date.accessioned2024-01-19T22:13:05Z
dc.date.available2024-01-19T22:13:05Z
dc.date.issued2023
dc.description.abstractGlomeruloesclerosis focal y segmentaria, también es llamada hialinosis focal y segmentaria, hace referencia a un patrón histológico, pero que indica un síndrome clínico patológico, siendo este una característica posiblemente de seis etiologías subyacentes distintas que como se ha venido mencionando lo característico que se va a observar es la cicatrización del glomérulo de forma progresiva, de tal forma que estas etiologías comparten un tema común de lesión y depleción de los podocitos, lo que se concluye no es una enfermedad única, sino un patrón morfológico de lesión que se desarrolla a partir de una amplia gama de etiologías. Objetivo: Evaluar las características clínico-patológicas de la podocitopatía por glomeruloesclerosis focal y segmentaria por microscopia electrónica en la región caribe colombiana Métodos: Se presentaron las variables cuantitativas como medianas y rangos intercuartílicos, mientras que las variables categóricas se describieron con frecuencias absolutas y relativas. El análisis incluyó pruebas como el test de Wilcoxon para las medianas según el sexo y la prueba exacta de Fisher para variables categóricas. Se empleó análisis de correspondencia múltiple para explorar relaciones entre hallazgos de microscopía y variables clínicas. La normalidad se evaluó con la prueba de Shapiro-Wilk, considerando p < 0.05 como significativo. Se utilizó el software R-CRAN versión 4.3.2 para los análisis estadísticos.spa
dc.description.abstractFocal segmental glomerulosclerosis, also known as focal and segmental hyalinosis, refers to a histological pattern indicating a clinical-pathological syndrome. This pattern is likely a characteristic of six distinct underlying etiologies. As previously mentioned, the common feature observed is progressive glomerular scarring. These etiologies share a common theme of podocyte injury and depletion, suggesting it is not a singular disease but a morphological pattern arising from a wide range of causes. Objective: To evaluate Clinical-pathological characteristics of podocytopathy due to focal segmental glomerulosclerosis by electron microscopy in the Colombian Caribbean region. Methods: Quantitative variables were presented as medians and interquartile ranges, while categorical variables were described using absolute and relative frequencies. Analysis included tests such as the Wilcoxon rank-sum test for medians by gender and Fisher's exact test for categorical variables. Multiple correspondence analysis explored relationships between microscopy findings and clinical variables. Data normality was assessed with the Shapiro-Wilk test, considering p < 0.05 as significant. Statistical analyses were performed using R-CRAN software version 4.3.2.eng
dc.format.mimetypepdfspa
dc.identifier.urihttps://hdl.handle.net/20.500.12442/13829
dc.language.isospaspa
dc.publisherEdiciones Universidad Simón Bolívarspa
dc.publisherFacultad de Ciencias de la Saludspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacionaleng
dc.rights.accessrightsinfo:eu-repo/semantics/restrictedAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectGlomeruloesclerosis focal y segmentariaspa
dc.subjectMicroscopia electrónicaspa
dc.subjectRubulopatíaspa
dc.subjectFocal segmental glomerulosclerosiseng
dc.subjectElectron microscopyeng
dc.subjectTubulopathyeng
dc.titleCaracterísticas clínico-patológicas de la podocitopatía por glomeruloesclerosis focal y segmentariapor microscopia electrónica en la región caribe colombianaspa
dc.type.driverinfo:eu-repo/semantics/otherspa
dc.type.spaOtrosspa
dcterms.referencesDe Luis Román D, Bustamante J. Aspectos nutricionales en la insuficiencia renal. Nefrologia. 2008;28(3):333–42.spa
dcterms.referencesGainza FJ. INSUFICIENCIA RENAL AGUDA. 2023;1–23.spa
dcterms.referencesVaidya SR, Aeddula NR. Chronic Renal Failure. StatPearls. 2023.eng
dcterms.referencesGyurászová M, Gurecká R, Bábíčková J, Tóthová Ľ. Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkers. Oxid Med Cell Longev. 2020;2020:5478708.eng
dcterms.referencesRapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites. Int J Mol Sci. 2019 Dec;21(1).eng
dcterms.referencesPanizo S, Martínez-Arias L, Alonso-Montes C, Cannata P, Martín-Carro B, Fernández-Martín JL, et al. Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences. Int J Mol Sci [Internet]. 2021 Jan 2;22(1). Available from: http://www.ncbi.nlm.nih.gov/pubmed/33401711eng
dcterms.referencesMartens CR, Kirkman DL, Edwards DG. The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise. Exerc Sport Sci Rev. 2016 Jan;44(1):12–9.eng
dcterms.referencesRisso MA, Sallustio S, Sueiro V, Bertoni V, Gonzalez-Torres H, Musso CG. The Importance of Tubular Function in Chronic Kidney Disease. Int J Nephrol Renovasc Dis [Internet]. 2019 Dec;2019(12):257–62. Available from: https://www.dovepress.com/the-importance-of-tubular-function-in-chronic-kidney-disease-peer-reviewed-article-IJNRDeng
dcterms.referencesMa K, Gao W, Xu H, Liang W, Ma G. Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome. J Renin Angiotensin Aldosterone Syst. 2022;2022:3239057.eng
dcterms.referencesCabrera SS. Definición y clasificación de los estadios de la enfermedad renal crónica . Prevalencia . de riesgo de enfermedad renal crónica. NEFROLOGIA. 2004;24(6):27–34.spa
dcterms.referencesChen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA [Internet]. 2019 Oct 1;322(13):1294–304. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31573641eng
dcterms.referencesNordheim E, Geir Jenssen T. Chronic kidney disease in patients with diabetes mellitus. Endocr Connect [Internet]. 2021 Apr 29;10(5):R151–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33830068eng
dcterms.referencesHovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003 Apr;26(4):1258–64.eng
dcterms.referencesSica DA. The kidney and hypertension: causes and treatment. J Clin Hypertens (Greenwich). 2008 Jul;10(7):541–8.eng
dcterms.referencesJara A, Mezzano S. [Vascular damage in chronic kidney disease]. Rev Med Chil. 2008 Nov;136(11):1476–84.eng
dcterms.referencesTaddei S, Nami R, Bruno RM, Quatrini I, Nuti R. Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail Rev. 2011 Nov;16(6):615–20.eng
dcterms.referencesBidani AK, Griffin KA. Pathophysiology of Hypertensive Renal Damage. Hypertension. 2004 Nov;44(5):595–601.eng
dcterms.referencesSun D, Wang J, Shao W, Wang J, Yao L, Li Z, et al. Pathogenesis and Damage Targets of Hypertensive Kidney Injury. J Transl Intern Med. 2020 Dec;8(4):205–9.eng
dcterms.referencesAkbar S, Bokhari SRA. Polycystic Kidney Disease. StatPearls. 2023.eng
dcterms.referencesRishor-Olney CR, Hinson MR. Obstructive Uropathy. StatPearls. 2023.eng
dcterms.referencesKazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl. 2013 Dec;3(4):368–71.eng
dcterms.referencesDamtie S, Biadgo B, Baynes HW, Ambachew S, Melak T, Asmelash D, et al. Chronic Kidney Disease and Associated Risk Factors Assessment among Diabetes Mellitus Patients at A Tertiary Hospital, Northwest Ethiopia. Ethiop J Health Sci. 2018 Nov;28(6):691–700.eng
dcterms.referencesThomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008 Jun;35(2):329–44, vii.eng
dcterms.referencesHashmi MF, Benjamin O, Lappin SL. End-Stage Renal Disease. StatPearls. 2023.eng
dcterms.referencesPergola PE, Pecoits-Filho R, Winkelmayer WC, Spinowitz B, Rochette S, Thompson-Leduc P, et al. Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review. PharmacoEconomics - open. 2019 Dec;3(4):463–78.eng
dcterms.referencesDarlington O, Dickerson C, Evans M, McEwan P, Sörstadius E, Sugrue D, et al. Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review. Adv Ther. 2021 Feb;38(2):994–1010.eng
dcterms.referencesHull KL, Adenwalla SF, Topham P, Graham-Brown MP. Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist. Clin Med. 2022 Jan;22(1):34–40.eng
dcterms.referencesPugh D, Gallacher PJ, Dhaun N. Management of Hypertension in Chronic Kidney Disease. Drugs. 2019 Mar;79(4):365–79.eng
dcterms.referencesGounden V, Bhatt H, Jialal I. Renal Function Tests. StatPearls. 2023.eng
dcterms.referencesAdejumo OA, Okaka EI, Okwuonu CG, Iyawe IO, Odujoko OO. Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria. Ghana Med J. 2016 Mar;50(1):31–8.eng
dcterms.referencesBouvet BR, Paparella C V., Arriaga SMM, Monje AL, Amarilla AM, Almará AM. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metabol. 2014 Nov;58(8):798–801.eng
dcterms.referencesMadalena LB, Facio ML, Bresciani PD, Fraind SA, Alejandre ME, Pandolfo M, et al. Excreción de proteínas de bajo peso molecular en pacientes con proteinuria a cadena liviana como marcadoras de disfunción renal. Acta Bioquim Clin Latinoam. 2004;38(1):17–22.spa
dcterms.referencesWu M-T, Lam K-K, Lee W-C, Hsu K-T, Wu C-H, Cheng B-C, et al. Albuminuria, proteinuria, and urinary albumin to protein ratio in chronic kidney disease. J Clin Lab Anal. 2012 Feb;26(2):82–92.eng
dcterms.referencesMoreno JA, Sevillano Á, Gutiérrez E, Guerrero-Hue M, Vázquez-Carballo C, Yuste C, et al. Glomerular Hematuria: Cause or Consequence of Renal Inflammation? Int J Mol Sci. 2019 May;20(9).eng
dcterms.referencesInoue K, Streja E, Tsujimoto T, Kobayashi H. Urinary albumin-to-creatinine ratio within normal range and all-cause or cardiovascular mortality among U.S. adults enrolled in the NHANES during 1999-2015. Ann Epidemiol. 2021 Mar;55:15–23.eng
dcterms.referencesShaikh H, Hashmi MF, Aeddula NR. Anemia of Chronic Renal Disease [Internet]. StatPearls. 2023. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4975372eng
dcterms.referencesArnold R, Issar T, Krishnan A V, Pussell BA. Neurological complications in chronic kidney disease. JRSM Cardiovasc Dis [Internet]. 2016;5:2048004016677687. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27867500eng
dcterms.referencesKaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial [Internet]. 2006;19(4):317–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16893410eng
dcterms.referencesEspi M, Koppe L, Fouque D, Thaunat O. Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells. Toxins (Basel) [Internet]. 2020 May 6;12(5). Available from: http://www.ncbi.nlm.nih.gov/pubmed/32384617eng
dcterms.referencesFevrier-Paul A, Soyibo AK, Mitchell S, Voutchkov M. Role of Toxic Elements in Chronic Kidney Disease. J Heal Pollut [Internet]. 2018 Dec;8(20):181202. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30560001eng
dcterms.referencesWarrens H, Banerjee D, Herzog CA. Cardiovascular Complications of Chronic Kidney Disease: An Introduction. Eur Cardiol [Internet]. 2022 Feb;17:e13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/35620357eng
dcterms.referencesSahadevan M, Kasiske BL. Hyperlipidemia in kidney disease: causes and consequences. Curr Opin Nephrol Hypertens [Internet]. 2002 May;11(3):323–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11981263eng
dcterms.referencesSpoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol [Internet]. 2016 Dec 1;311(6):F1087–108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27707707eng
dcterms.referencesRosenstein K, Tannock LR. Dyslipidemia in Chronic Kidney Disease [Internet]. Endotext. 2000. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23067652eng
dcterms.referencesDialysis in chronic kidney disease [Internet]. Institute for Quality and Efficiency in Health Care (IQWIG). Colonia, Alemania; 2018. Available from: //www.ncbi.nlm.nih.gov/books/NBK492979/eng
dcterms.referencesCarminatti M, Tedesco-Silva H, Silva Fernandes NM, Sanders-Pinheiro H. Chronic kidney disease progression in kidney transplant recipients: A focus on traditional risk factors. Nephrology (Carlton) [Internet]. 2019 Feb;24(2):141–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30159972eng
dcterms.referencesGhanta M, Jim B. Renal Transplantation in Advanced Chronic Kidney Disease Patients. Med Clin North Am [Internet]. 2016 May;100(3):465–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27095639eng
dcterms.referencesHole B, Hemmelgarn B, Brown E, Brown M, McCulloch MI, Zuniga C, et al. Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world. Kidney Int Suppl [Internet]. 2020 Mar;10(1):e86–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32149013eng
dcterms.referencesSultan S, Nasir K, Qureshi R, Dhrolia M, Ahmad A. Assessment of the Nutritional Status of the Hemodialysis Patients by Anthropometric Measurements. Cureus [Internet]. 2021 Oct;13(10):e18605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34765364eng
dcterms.referencesLordsleem A, Gueiros APS, Gueiros JE de B, Markman Filho B, Victor EG. Cardiac evaluation of patients with chronic kidney disease: what lessons? J Bras Nefrol [Internet]. 2012 Mar;34(1):8–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22441176eng
dcterms.referencesMcKercher CM, Venn AJ, Blizzard L, Nelson MR, Palmer AJ, Ashby MA, et al. Psychosocial factors in adults with chronic kidney disease: characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study. BMC Nephrol [Internet]. 2013 Apr 12;14:83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23586969eng
dcterms.referencesAhmed S, Mothi SS, Sequist T, Tangri N, Khinkar RM, Mendu ML. The Kidney Failure Risk Equation Score and CKD Care Delivery Measures: A Cross-sectional Study. Kidney Med [Internet]. 2022 Jan;4(1):100375. Available from: http://www.ncbi.nlm.nih.gov/pubmed/35072040eng
dcterms.referencesFelipe Inserra, María Lía Torres, Alberto Alles CB. Evaluación de la función renal para la detección y seguimiento de la enfermedad renal crónica. Documento multidisciplinario de consenso 2021. Especial atención sobre situaciones clínicas específicas. FABA. 2022;56.spa
dcterms.referencesGómez-Carracedo A, Arias-Muñana E, Jiménez-Rojas C. Enfermedad renal crónica - Progesión de la IRC. Nefrol al dia [Internet]. 2016;36(1):[48-55]. Available from: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952016000500048&lng=es&nrm=iso&tlng=esspa
dcterms.referencesKwek JL, Pang HQJ, Li H, Lim WWL, Choo JCJ, Choong HL, et al. Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort. Singapore Med J [Internet]. 2022 Jun;63(6):313–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/36043308eng
dcterms.referencesGrams ME, Brunskill NJ, Ballew SH, Sang Y, Coresh J, Matsushita K, et al. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts. J Am Soc Nephrol [Internet]. 2023 Mar 1;34(3):482–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/36857500eng
dcterms.referencesHundemer GL, Tangri N, Sood MM, Ramsay T, Bugeja A, Brown PA, et al. Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKD. Clin J Am Soc Nephrol. 2020 Oct;15(10):1424–32.eng
dcterms.referencesMatsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA [Internet]. 2012 May 9;307(18):1941–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22570462eng
dcterms.referencesCoca SG, Zabetian A, Ferket BS, Zhou J, Testani JM, Garg AX, et al. Evaluation of Short-Term Changes in Serum Creatinine Level as a Meaningful End Point in Randomized Clinical Trials. J Am Soc Nephrol [Internet]. 2016 Aug;27(8):2529–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26712525eng
dcterms.referencesGómez-Carracedo A, Arias-Muñana E, Jiménez-Rojas C. Enfermedad renal crónica - Progesión de la IRC. Nefrol al dia. 2016;36(1):[48-55].spa
dcterms.referencesLópez CAN. Predicción de progresión de enfermedad renal crónica en pacientes diabéticos por la fórmula Kidney Failure Risk Equation (KFRE) en población mexicana. Tecnologico de Monterrey. 2 Instituto Tecnológico y de Estudios Superiores de Monterrey Escuela de Medicina y Ciencias de la Salud; 2020.spa
dcterms.referencesBhachu HK, Fenton A, Cockwell P, Aiyegbusi O, Kyte D, Calvert M. Use of the kidney failure risk equation to inform clinical care of patients with chronic kidney disease: a mixed-methods systematic review. BMJ Open. 2022 Jan;12(1):e055572.eng
dcterms.referencesCarrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018 Mar;14(3):151–64.eng
dcterms.referencesKovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022 Apr;12(1):7–11.eng
dcterms.referencesLewandowski MJ, Krenn S, Kurnikowski A, Bretschneider P, Sattler M, Schwaiger E, et al. Chronic kidney disease is more prevalent among women but more men than women are under nephrological care : Analysis from six outpatient clinics in Austria 2019. Wien Klin Wochenschr. 2023 Feb;135(3– 4):89–96.eng
dcterms.referencesMallappallil M, Friedman EA, Delano BG, McFarlane SI, Salifu MO. Chronic kidney disease in the elderly: evaluation and management. Clin Pract (Lond). 2014;11(5):525–35.eng
dcterms.referencesHamrahian SM, Falkner B. Hypertension in Chronic Kidney Disease. Adv Exp Med Biol. 2017;956:307–25.eng
dcterms.referencesGeorgianos PI, Agarwal R. Hypertension in chronic kidney disease—treatment standard 2023. Nephrol Dial Transplant. 2023 Jun;eng
dcterms.referencesAbraham HMA, White CM, White WB. The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases. Drug Saf. 2015 Jan;38(1):33–54.eng
dcterms.referencesBravo-Zúñiga J, Saldarriaga EM, Chávez-Gómez R, Gálvez-Inga J, Valdivia-Vega R, Villavicencio-Carranza M, et al. Effectiveness of adherence to a renal health program in a health network in Peru. Rev Saude Publica. 2020 Aug;54:80.eng
dcterms.referencesLi PK-T, Garcia-Garcia G, Lui S-F, Andreoli S, Fung WW-S, Hradsky A, et al. Kidney health for everyone everywhere - from prevention to detection and equitable access to care. Brazilian J Med Biol Res = Rev Bras Pesqui medicas e Biol. 2020;53(3):e9614.eng
dcterms.referencesKattah AG, Garovic VD. Understanding sex differences in progression and prognosis of chronic kidney disease. Ann Transl Med. 2020 Jul;8(14):897.eng
dcterms.referencesPrasad R, Jha RK, Keerti A. Chronic Kidney Disease: Its Relationship With Obesity. Cureus. 2022 Oct;14(10):e30535.eng
dcterms.referencesBello AK, Alrukhaimi M, Ashuntantang GE, Basnet S, Rotter RC, Douthat WG, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl. 2017 Oct;7(2):122–9.eng
dcterms.referencesAbcar AC, Chan L, Yeoh H. What To Do for the Patient with Minimally Elevated Creatinine Level? Perm J. 2004;8(1):51–3.eng
dcterms.referencesO’Seaghdha CM. A Risk Score for Chronic Kidney Disease in the General Population. HHS Author Manuscripts. 2013;eng
dcterms.referencesKamath CC, Dobler CC, Lampman MA, Erwin PJ, Matulis J, Elrashidi M, et al. Implementation strategies for interventions to improve the management of chronic kidney disease (CKD) by primary care clinicians: protocol for a systematic review. BMJ Open. 2019 Aug;9(8):e027206.eng
dcterms.referencesAmeh OI, Ekrikpo U, Bello A, Okpechi I. Current Management Strategies of Chronic Kidney Disease in Resource-Limited Countries. Int J Nephrol Renovasc Dis. 2020;13:239–51.eng
dcterms.referencesGarcía GG, Iyengar A, Kaze F, Kierans C, Padilla-Altamira C, Luyckx VA. Sex and gender differences in chronic kidney disease and access to care around the globe. Semin Nephrol. 2022 Mar;42(2):101–13.eng
oaire.versioninfo:eu-repo/semantics/acceptedVersionspa
sb.programaEspecialización en Nefrologíaspa
sb.sedeSede Barranquillaspa

Archivos

Bloque original
Mostrando 1 - 2 de 2
Cargando...
Miniatura
Nombre:
PDF_Resumen.pdf
Tamaño:
160.22 KB
Formato:
Adobe Portable Document Format
No hay miniatura disponible
Nombre:
PDF.pdf
Tamaño:
542.54 KB
Formato:
Adobe Portable Document Format

Colecciones